Document is current
Any future updates will be listed below
-
Authors
Di Scala, Lilla
Bacchi, Marisa
Bayer, Bjørn
Turricchia, Stefano
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00660179 at ClinicalTrials.govDocuments that mention this clinical trial
P17 Pharmacokinetics of macitentan in patients with portopulmonary hypertension: findings from the PORTICO sub-study
https://doi.org/10.1136/thorax-2018-212555.175
Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study
https://doi.org/10.1007/s12325-022-02253-8
Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial
https://doi.org/10.1007/s40256-017-0260-1
-
Funding
Funding for this research was provided by:
Actelion Pharmaceuticals
- License Information
-
More Information
Article History
Received: 1 June 2022
Accepted: 30 June 2022
First Online: 1 August 2022
